Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients

Radiology. 1997 Aug;204(2):545-52. doi: 10.1148/radiology.204.2.9240551.

Abstract

Purpose: To determine the value of gray-scale ultrasonography (US) and Doppler US in the prediction, diagnosis, and prognostic assessment of hepatic veno-occlusive disease (HVOD).

Materials and methods: One hundred patients (median age, 22 years; range, 18 months to 59 years) receiving total body irradiation or busulfan therapy as intensive treatment before hematopoietic stem cell transplantation were studied prospectively. Each patient underwent gray-scale and Doppler US examination before transplantation and weekly thereafter while hospitalized (about four examinations per patient). Seven gray-scale morphologic criteria and seven Doppler criteria were studied, yielding three individual scores: gray-scale score, Doppler score, and total score.

Results: Twenty-five patients developed HVOD; nine of these patients died. Positive predictive values of the 14 criteria were 31%-95%, and negative predictive values were 85%-96%. The three scores correlated with the clinical diagnosis of HVOD. Depending on the cutoff value, the positive predictive value of the total score was 44%-89% and the negative predictive value was 91%-98%. The gray-scale and Doppler criteria differed significantly between patients with HVOD and those with graft-versus-host disease of the liver (P = 10(-4)).

Conclusion: Even if there is overlap in findings between patients with and those without HVOD, gray-scale and Doppler US are valid for positive and differential diagnosis and have predictive and prognostic relevance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Busulfan / adverse effects
  • Busulfan / therapeutic use
  • Child
  • Diagnosis, Differential
  • Female
  • Graft vs Host Disease / diagnostic imaging
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hepatic Veno-Occlusive Disease / diagnostic imaging*
  • Hepatic Veno-Occlusive Disease / etiology*
  • Hepatic Veno-Occlusive Disease / mortality
  • Humans
  • Hypertension, Portal / diagnostic imaging
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Liver Diseases / diagnostic imaging
  • Male
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Sensitivity and Specificity
  • Transplantation Conditioning / adverse effects*
  • Ultrasonography, Doppler*
  • Whole-Body Irradiation / adverse effects

Substances

  • Immunosuppressive Agents
  • Busulfan